MILLENNIUM MANAGEMENT LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$6,183,480
-2.3%
136,230
+20.8%
0.00%0.0%
Q2 2023$6,329,617
+53727.9%
112,747
-56.6%
0.00%
-57.1%
Q1 2023$11,759
+2280.4%
259,977
+2040.8%
0.01%
Q4 2022$494
-99.9%
12,144
+26.4%
0.00%
Q3 2022$628,000
-48.3%
9,611
-51.9%
0.00%
-100.0%
Q2 2022$1,215,000
-71.2%
20,000
-70.2%
0.00%
-66.7%
Q1 2022$4,217,000
-86.5%
67,188
-83.7%
0.00%
-81.2%
Q4 2021$31,325,000
+26.2%
413,366
+86.5%
0.02%
+6.7%
Q3 2021$24,815,000
+27.8%
221,700
+84.8%
0.02%
+36.4%
Q2 2021$19,417,000
+19.7%
119,939
-9.9%
0.01%
-8.3%
Q1 2021$16,220,000
+70.4%
133,112
+114.1%
0.01%
+100.0%
Q4 2020$9,521,000
+184.2%
62,185
+36.4%
0.01%
+20.0%
Q2 2020$3,350,000
-82.4%
45,592
-85.4%
0.01%
-79.2%
Q4 2019$19,029,000
+335.8%
312,433
+193.3%
0.02%
+242.9%
Q3 2019$4,366,000
+46.6%
106,538
+58.6%
0.01%
+75.0%
Q3 2018$2,979,000
+33.3%
67,179
-29.4%
0.00%
+33.3%
Q4 2017$2,234,000
+66.1%
95,130
+26.4%
0.00%
+50.0%
Q3 2017$1,345,000
+154.3%
75,272
+128.1%
0.00%
+100.0%
Q2 2017$529,000
+119.5%
33,000
+177.0%
0.00%0.0%
Q4 2016$241,00011,9130.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders